{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:43:40Z","timestamp":1768610620574,"version":"3.49.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014468","name":"Mallinckrodt Pharmaceuticals Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014468","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery Case Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijscr.2025.112140","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:12:17Z","timestamp":1761898337000},"page":"112140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Use of repository corticotropin injection for the prophylaxis of corneal graft rejection in high-risk patients: A case series"],"prefix":"10.1097","volume":"137","author":[{"given":"Steven M.","family":"Silverstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijscr.2025.112140_bb0005","series-title":"StatPearls [Internet]","article-title":"Corneal graft rejection","author":"Gurnani","year":"2023"},{"issue":"6","key":"10.1016\/j.ijscr.2025.112140_bb0010","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ajo.2005.07.024","article-title":"The impact of corneal allograft rejection on the long-term outcome of corneal transplantation","volume":"140","author":"Coster","year":"2005","journal-title":"Am. J. Ophthalmol."},{"issue":"Suppl. 9","key":"10.1016\/j.ijscr.2025.112140_bb0015","first-page":"006","article-title":"Corneal allograft rejection: immunopathogenesis to therapeutics","volume":"2013","author":"Qazi","year":"2013","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1016\/j.ijscr.2025.112140_bb0025","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1100\/tsw.2010.173","article-title":"The melanocortin system in control of inflammation","volume":"10","author":"Catania","year":"2010","journal-title":"Sci. World J."},{"issue":"4","key":"10.1016\/j.ijscr.2025.112140_bb0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/cpdd.1020","article-title":"Pharmacokinetics and pharmacodynamics of repository corticotropin injection compared with synthetic ACTH1-24 depot and methylprednisolone in healthy subjects","volume":"11","author":"Poola","year":"2022","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"7","key":"10.1016\/j.ijscr.2025.112140_bb0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/cpdd.894","article-title":"Comparison of steroidogenic exposure following the administration of repository corticotropin injection with a synthetic ACTH1-24 depot and methylprednisolone in healthy subjects","volume":"10","author":"Wang","year":"2021","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"10","key":"10.1016\/j.ijscr.2025.112140_bb0040","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40261-023-01303-5","article-title":"Acthar\u00ae Gel treatment for patients with autoimmune and inflammatory diseases: an historical perspective and characterization of clinical evidence","volume":"43","author":"Kaplan","year":"2023","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ijscr.2025.112140_bb0045","series-title":"StatPearls [Internet]","article-title":"Cornea transplantation","author":"Maghsoudlou","year":"2024"},{"issue":"4","key":"10.1016\/j.ijscr.2025.112140_bb0050","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s40123-021-00400-y","article-title":"Repository corticotropin injection (Acthar\u00aeGel) for refractory severe noninfectious keratitis: efficacy and safety from a phase 4, multicenter, open-label study","volume":"10","author":"Wirta","year":"2021","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.ijscr.2025.112140_bb0055","article-title":"Revised Preferred Reporting of Case Series in Surgery (PROCESS) guideline: an update for the age of artificial intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Premier J. Sci."},{"issue":"5","key":"10.1016\/j.ijscr.2025.112140_bb0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/10799893.2020.1818094","article-title":"Distinct binding and signaling activity of Acthar Gel compared to other melanocortin receptor agonists","volume":"41","author":"Huang","year":"2021","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"Suppl. 3","key":"10.1016\/j.ijscr.2025.112140_bb0065","first-page":"777","article-title":"Melanocortin receptor mediated anti-inflammatory effect of repository corticotropin injection on human monocyte-derived macrophages [ECTRIMS-ACTRIMS abstract EP1481]","volume":"23","author":"Healy","year":"2017","journal-title":"Mult. Scler. J."},{"issue":"4","key":"10.1016\/j.ijscr.2025.112140_bb0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/jir.2022.0257","article-title":"Acthar Gel inhibits the activation of CD4+ and CD8+ T cells","volume":"43","author":"Wright","year":"2023","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.ijscr.2025.112140_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0823-y","article-title":"Direct effects of HP Acthar Gel on human B lymphocyte activation in vitro","volume":"17","author":"Olsen","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.ijscr.2025.112140_bb0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cei.13089","article-title":"Repository corticotrophin injection exerts direct acute effects on human B cell gene expression distinct from the actions of glucocorticoids","volume":"192","author":"Benko","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijscr.2025.112140_bb0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preteyeres.2016.09.003","article-title":"Steroid-induced ocular hypertension\/glaucoma: focus on pharmacogenomics and implications for precision medicine","volume":"56","author":"Fini","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.ijscr.2025.112140_bb0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/ICO.0000000000003312","article-title":"Long-term risk of steroid-induced ocular hypertension\/glaucoma with topical prednisolone acetate 1% after descemet stripping endothelial keratoplasty","volume":"43","author":"Price","year":"2024","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.ijscr.2025.112140_bb0095","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamaophthalmol.2015.1823","article-title":"Incidence, risk factors, and timing of elevated intraocular pressure after intravitreal triamcinolone acetonide injection for macular edema secondary to retinal vein occlusion: SCORE study report 15","volume":"133","author":"Aref","year":"2015","journal-title":"JAMA Ophthalmol."},{"issue":"6","key":"10.1016\/j.ijscr.2025.112140_bb0100","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/IAE.0000000000001004","article-title":"Intraocular pressure in patients with diabetic macular edema treated with dexamethasone intravitreal implant in the 3-year MEAD study","volume":"36","author":"Maturi","year":"2016","journal-title":"Retina"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261225013264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261225013264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:39:40Z","timestamp":1768387180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210261225013264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":19,"alternative-id":["S2210261225013264"],"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2025.112140","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of repository corticotropin injection for the prophylaxis of corneal graft rejection in high-risk patients: A case series","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijscr.2025.112140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Ltd on behalf of IJS Publishing Group Limited.","name":"copyright","label":"Copyright"}],"article-number":"112140"}}